InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Shawver Laura, Chief Executive Officer. Insider active across 3 companies, notably Silverback Therapeutics, Inc.. In total, 23 filings have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €2.6m. Activity tracked since 1 February 2022. The latest transaction was filed on 7 April 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Shawver Laura
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
22,509 shares@ US$4.852.8% of flowCommon StockSEC:0001415889-25-010395:0
27,493 shares@ US$4.853.4% of flowCommon StockSEC:0001415889-25-010395:1
50,002 shares@ US$12.30115.7% of flowCommon StockSEC:0001415889-25-010395:2
400 shares@ US$4.850.1% of flowCommon StockSEC:0001415889-25-007438:0
9,064 shares@ US$3.150.8% of flowCommon StockSEC:0001415889-25-002955:0
40,936 shares@ US$4.855.4% of flowCommon StockSEC:0001415889-25-002955:1
50,000 shares@ US$12.311316.7% of flowCommon StockSEC:0001415889-25-002955:2
50,000 shares@ US$3.154.3% of flowCommon StockSEC:0001415889-25-001053:0
50,000 shares@ US$11.101315.0% of flowCommon StockSEC:0001415889-25-001053:1
67,616 shares@ US$1.272.3% of flowCommon StockSEC:0001415889-24-028350:0
2,997 shares@ US$1.270.1% of flowCommon StockSEC:0001209191-23-048254:0
97,003 shares@ US$1.273.2% of flowCommon StockSEC:0001209191-23-048254:1
100,000 shares@ US$7.705219.8% of flowCommon StockSEC:0001209191-23-048254:2
26,107 shares@ US$1.270.8% of flowCommon StockSEC:0001209191-23-044845:0
18,715 shares@ US$1.270.6% of flowCommon StockSEC:0001209191-23-044534:0
8,858 shares@ US$1.270.3% of flowCommon StockSEC:0001209191-23-041866:0
26,520 shares@ US$1.270.9% of flowCommon StockSEC:0001209191-23-041716:0
73,059 shares@ US$1.272.4% of flowCommon StockSEC:0001209191-23-034090:0
12,099 sharesCommon StockSEC:0001209191-23-032515:0
43,896 shares@ US$4.585.6% of flowCommon StockSEC:0001209191-23-028507:0
78,740 shares@ US$1.27100.0% of flowCommon StockSEC:0001209191-22-045023:0
68,107 shares0Common StockSEC:0001209191-22-027168:0
27,500 shares0Common StockSEC:0001209191-22-006435:0
23 of 23 declarations
About Shawver Laura
Laura Shawver is the Chief Executive Officer at Silverback Therapeutics, Inc. She leads the company by defining strategy and overseeing operations. Her expertise in the sector is crucial for innovation and the development of new treatments.
